Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/175110
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCorral, Javier-
dc.contributor.authorParés, David-
dc.contributor.authorGarcía Cuyás, Francesc-
dc.contributor.authorRevollo, Boris-
dc.contributor.authorChamorro, Ana-
dc.contributor.authorLecumberri, Carla-
dc.contributor.authorTarrats, Antoni-
dc.contributor.authorCastella, Eva-
dc.contributor.authorPiñol, Marta-
dc.contributor.authorClotet i Sala, Bonaventura-
dc.contributor.authorVidela, Sebas-
dc.contributor.authorSirera, Guillem-
dc.date.accessioned2021-03-15T12:27:32Z-
dc.date.available2021-03-15T12:27:32Z-
dc.date.issued2021-02-14-
dc.identifier.urihttp://hdl.handle.net/2445/175110-
dc.description.abstractThis single-center, retrospective cohort study sought to estimate the cumulative incidence in HIV-1-infected patients of biopsy-proven high-grade anal intraepithelial neoplasia (HGAIN) recurrence after infrared coagulation (IRC) treatment. The study was based on data from a prospectively compiled database of 665 HIV-1-infected outpatients who attended a hospital Clinical Proctology/HIV Unit between January 2012 and December 2015. Patient records were checked to see which ones had received IRC treatment but later experienced a recurrence of HGAIN. Cytology samples were also checked for the presence of human papilloma virus (HPV). A total of 81 of the 665 patients (12%, 95%CI: 10-15%), of whom 65 were men and 16 women, were diagnosed with HGAIN and again treated with IRC. Of these 81, 20 (25%) experienced recurrent HGAIN, this incidence being true of both men (16/65, 95%CI: 19-57%) and women (4/16, 95%CI: 10-50%). The median time to recurrence was 6 (2-19) months overall, 6 (2-19) months in men, and 4 (2-6) months in women. HPV infection was detected in all patients except two, with HPV-16 being the most common genotype. This rate of incidence of recurrent HGAIN following IRC treatment is consistent with other reports and highlights the importance of continued post-treatment surveillance, particularly in the first year.-
dc.format.extent7 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI AG-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pathogens10020208-
dc.relation.ispartofPathogens, 2021, vol. 10, num. 208-
dc.relation.urihttps://doi.org/10.3390/pathogens10020208-
dc.rightscc by (c) Corral, Javier et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subject.classificationInfeccions per VIH-
dc.subject.classificationMalalties de l'anus-
dc.subject.otherHIV infections-
dc.subject.otherDiseases of the anus-
dc.titleIncidence of Recurrent High-Grade Anal Dysplasia in HIV-1-Infected Men and Women Following Infrared Coagulation Ablation: A Retrospective Cohort Study-
dc.typeinfo:eu-repo/semantics/article-
dc.date.updated2021-03-11T11:16:01Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid33672969-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
pathogens-10-00208-v2.pdf229.28 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons